Stocks
Zynerba Pharmaceuticals (ZYNE) R&D US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| R&D, bln rub | 27.2 | 20.4 | 35.7 | 21.4 | 21.1 | 24.8 | |||
| Changes by years, y/y, % | +19% | -25% | +75% | -40% | -2% | -1.5% | |||
Zynerba Pharmaceuticals. R&D, bln rub
Zynerba Pharmaceuticals. R&D, changes, %
Zynerba Pharmaceuticals. R&D, sum by quarters, bln rub
Zynerba Pharmaceuticals (ZYNE) R&D US GAAP (quarter values) |
||||||||
| 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
| R&D, bln rub | 5.45 | 5.04 | 5.47 | 7.08 | 7.17 | 24.8 | ||
| Changes by years, y/y, % | 0% | -21% | +9% | +38% | +32% | |||
| Changes by quarters, q/q, % | +6% | -7% | +8% | +29% | +1% | |||
